RT-LAMP HIV-1 Nucleic Acid Detection via Isothermal Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current HIV diagnostic tests, especially rapid antibody tests, are not sensitive enough to detect early HIV infection, missing individuals during the post-infection but pre-seroconversion period, and there is a need for a more efficient point-of-care (POC) testing method that can accurately and timely diagnose HIV-1 nucleic acids.

Innovation Solution

Development of a highly sensitive and specific rapid HIV-1 nucleic acid amplification test (NAAT) using loop-mediated isothermal amplification (LAMP) or reverse transcription-LAMP (RT-LAMP) techniques that can amplify HIV-1 nucleic acids directly from whole blood, plasma, or saliva without the need for thermal cycling, allowing for early detection and minimal equipment requirements.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If rapid antibody tests are used for HIV screening, then the testing can be completed quickly at point-of-care with minimal equipment, but the sensitivity is insufficient to detect early HIV infection during the post-infection but pre-seroconversion period

Engineering Contradiction:
Improvetesting timeVSAvoiddetection sensitivity
Core Design Contradiction:
Loss of timeVSMeasurement precision

Solution Approach 1:

The invention changes the detection parameter from antibody detection to nucleic acid detection through RT-LAMP amplification, enabling detection during the pre-seroconversion period when antibodies are not yet present but viral nucleic acids are detectable

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention replaces the thermal cycling mechanism of traditional PCR with isothermal amplification using RT-LAMP, eliminating the need for complex thermal cyclers while maintaining nucleic acid detection capability at point-of-care settings

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If laboratory-based NAAT is used for HIV detection, then the detection sensitivity is high and can detect infection approximately two weeks earlier than antibody-based tests, but the testing requires complex equipment and cannot be performed at point-of-care

Engineering Contradiction:
Improvedetection sensitivityVSAvoidequipment requirements
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention substitutes the complex thermal cycling system with an isothermal amplification system using RT-LAMP, which only requires a simple heat block or water bath, thereby reducing equipment complexity while maintaining high detection sensitivity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention changes the amplification condition from cyclic temperature changes to constant temperature operation, simplifying the equipment requirements while preserving the ability to detect HIV nucleic acids with high sensitivity

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If traditional PCR is used for HIV nucleic acid amplification, then the detection sensitivity is high, but the thermal cycling process requires complex equipment and extended testing time

Engineering Contradiction:
Improvedetection sensitivityVSAvoidthermal cycling equipment
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention replaces the thermal cycling mechanism with isothermal amplification using RT-LAMP, which operates at a constant temperature (typically 60-65°C), eliminating the need for complex thermal cyclers and reducing equipment requirements

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Ease of operation

If rapid antibody tests are used, then the testing can be performed with minimal technical expertise, but they remain negative during the post-infection but pre-seroconversion period and miss early infections

Engineering Contradiction:
Improvetechnical expertise requiredVSAvoiddetection sensitivity
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The invention changes the detection target from antibodies to viral nucleic acids, enabling detection during the pre-seroconversion period while maintaining ease of operation through the use of isothermal amplification and simple detection methods

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The RT-LAMP assays provide early detection of HIV-1 up to 24 days earlier than rapid antibody tests, with high sensitivity and specificity, facilitating timely diagnosis and improving the detection of acute infections at the point of care with ease of use and minimal equipment needs.

Implementation Method 1

reverse transcription-LAMP (RT-LAMP) techniques that can amplify HIV-1 nucleic acids

Methodology Applied
Scientific EffectReverse transcription:

Implementation Method 2

Loop-mediated isothermal amplification (LAMP) or reverse transcription-LAMP (RT-LAMP) are examples of such an isothermal amplification technique

Methodology Applied
Scientific EffectLoop-mediated isothermal amplification:

Data Source

PatentUS10697028B2Detection of HIV-1 nucleic acids by reverse-transcription loop-mediated isothermal amplification
Publication Date: 2020.06.30 THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
  • US10697028B2 patent drawing

AI summary

Disclosed herein are methods of detecting HIV-1 nucleic acids in a sample (such as from a sample containing or suspected to contain HIV-1 nucleic acid). In some examples, the methods include loop-mediated isothermal amplification (LAMP) or reverse transcription-LAMP (RT-LAMP). In some examples, the methods include contacting a sample with one or more sets of LAMP primers specific for HIV-1 (such as LAMP primers specific for an HIV-1 integrase nucleic acid or LAMP primers specific for an HIV-1 reverse transcriptase nucleic acid) under conditions sufficient to produce an amplification product and detecting the amplification product. Sets of LAMP primers for detection of HIV-1 integrase nucleic acids (such as SEQ ID NOs: 8-14 or 8-27) and HIV-1 reverse transcriptase nucleic acids (such as SEQ ID NOs: 1-7) are provided herein.